Search Results - "Ceberio Hualde, L."

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients by Cervera, R, Serrano, R, Pons-Estel, G J, Ceberio-Hualde, L, Shoenfeld, Y, de Ramón, E, Buonaiuto, V, Jacobsen, S, Zeher, M M, Tarr, T, Tincani, A, Taglietti, M, Theodossiades, G, Nomikou, E, Galeazzi, M, Bellisai, F, Meroni, P L, Derksen, R H W M, de Groot, P G D, Baleva, M, Mosca, M, Bombardieri, S, Houssiau, F, Gris, J-C, Quéré, I, Hachulla, E, Vasconcelos, C, Fernández-Nebro, A, Haro, M, Amoura, Z, Miyara, M, Tektonidou, M, Espinosa, G, Bertolaccini, M L, Khamashta, M A

“…To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid syndrome (APS) during a 10-year-follow-up period and to compare the…”
Get more information

Clinical characteristics of adult patients with inborn errors of metabolism in Spain: A review of 500 cases from university hospitals by Pérez-López, J., Ceberio-Hualde, L., García-Morillo, J.S., Grau-Junyent, J.M., Hermida Ameijeiras, A., López-Rodríguez, M., Milisenda, J.C., Moltó Abad, M., Morales-Conejo, M., Nava Mateos, J.J.

“…Patients with inborn errors of metabolism (IEMs) have become an emerging and challenging group in the adult healthcare system whose needs should be known in…”
Get full text

Efficacy of Idursulfase therapy in patients with Mucopolysaccharidosis type II who initiated enzyme replacement therapy in adult age. A systematic review of the literature by Pérez-López, J., Moltó-Abad, M., Muñoz-Delgado, C., Morales-Conejo, M., Ceberio-Hualde, L., del Toro, M.

“…Enzyme replacement therapy (ERT) has been shown to decrease urine glycosaminoglycans (uGAGs) and liver and spleen volumes, and to improve clinical symptoms in…”
Get full text

Analysis of the manifestations and treatment of tuberous sclerosis complex in the Basque Country by Gutiérrez Zurimendi, G., Olmo Velasco, M., De Frutos Muñoyerro, G., Ceberio Hualde, L., Fernández Pereda, R., Llarena Ibarguren, R., Aizcorbe Gómez, M., Arruza Echevarría, A.

Get full text

Treatment of encephalopathy by means of valproic acid with carglumic acid: two case reports and a review of the literature by Nava-Mateos, J J, Roiz-Rey, P, Diaz Alvarez-Mediavilla, J, Cebrian-Novella, D, Gomez-Del Olmo, V, Ceberio-Hualde, L

“…Valproic acid (VPA) is a drug mainly used to treat epilepsy. Hyperammonaemic encephalopathy due to VPA is a rare but serious complication. The mechanism by…”
Get full text

Treatment of encephalopathy by means of valproic acid with carglumic acid. Reply by Nava-Mateos, J J, Roiz-Rey, P, Diaz Alvarez-Mediavilla, J, Cebrian-Novella, D, Gomez-Del Olmo, V, Ceberio-Hualde, L

Get full text

Réplica by Nava Mateos, Juan José, Roiz Rey, Patricia, Díaz Álvarez-Mediavilla, Jorge, Cebrián Novella, Diego, Gómez del Olmo, Vicente, Ceberio Hualde, Leticia

Get full text